Literature DB >> 6785803

Differential effects of opiate agonists-antagonists on morphine-induced hyperexcitability and analgesia in mice.

U Filibeck, C Castellano, A Oliverio.   

Abstract

The effects of two opiate agonists-antagonists, butorphanol (4.0 and 8.0 mg/kg) and buprenorphine (0.1 and 1.0 mg/kg), were assessed on locomotor activity and analgesia in DBA/2 and C57BL/6 mice. Different behavioral effects were evident in these strains, which might be characterized by different reactions to the effects of opiates and by differences in endorphin distributions and opiate receptor populations. In particular, buprenorphine acted as an agonist-antagonist to morphine in both strains while a dissociation of butorphanol effects was evident, depending on the strain considered. The clinical implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785803     DOI: 10.1007/BF00429203

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs.

Authors:  M J Rance
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  Analgesic effectiveness of the narcotic agonist-antagonists.

Authors:  R W Houde
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Genotype-dependent sensitivity to morphine: role of different opiate receptor populations.

Authors:  A Reggiani; F Battaini; H Kobayashi; P Spano; M Trabucchi
Journal:  Brain Res       Date:  1980-05-05       Impact factor: 3.252

4.  History and development of mixed opioid agonists, partial agonists and antagonists.

Authors:  W R Martin
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.

Authors:  A Wikler
Journal:  Adv Biochem Psychopharmacol       Date:  1973

6.  Mixed agonist-antagonist opiates and physical dependence.

Authors:  J J Jacob; G M Michaud; E C Tremblay
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.

Authors:  A Cowan; J W Lewis; I R Macfarlane
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

8.  The animal pharmacology of buprenorphine, an oripavine analgesic agent.

Authors:  A Cowan; J C Doxey; E J Harry
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

9.  Buprenorphine suppresses heroin use by heroin addicts.

Authors:  N K Mello; J H Mendelson
Journal:  Science       Date:  1980-02-08       Impact factor: 47.728

10.  Differential effects of localized lesions of n. accumbens on morphine- and amphetamine-induced locomotor hyperactivity in the C57BL/6J mouse.

Authors:  H Teitelbaum; P Giammatteo; G A Mickley
Journal:  J Comp Physiol Psychol       Date:  1979-08
View more
  5 in total

1.  Inbred strain differences in morphine-induced analgesia with the hot plate assay: a reassessment.

Authors:  J K Belknap; M Lamé; P W Danielson
Journal:  Behav Genet       Date:  1990-03       Impact factor: 2.805

2.  The effects of chronic buprenorphine on intake of heroin and cocaine in rats and its effects on nucleus accumbens dopamine levels during self-administration.

Authors:  Robert E Sorge; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2006-08-11       Impact factor: 4.530

3.  Tripelennamine enhances buprenorphine-, but not pentazocine-induced hyperactivity in mice.

Authors:  M Sansone; C Castellano; V Libri
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 4.  Opioids and behavior: genetic aspects.

Authors:  H R Frischknecht; B Siegfried; P G Waser
Journal:  Experientia       Date:  1988-06-15

5.  Thermal latency studies in opiate-treated mice.

Authors:  Noam Schildhaus; Eliana Trink; Chirs Polson; Louis Detolla; Betty M Tyler; George I Jallo; Sino Tok; Michael Guarnieri
Journal:  J Pharm Bioallied Sci       Date:  2014-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.